Dapxi 5mg (10 Tablet / Pack)

Dapxi 5mg is an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor indicated to optimize glycemic control and reduce cardiorenal complications in adults.

PKR 0.00

Quantity:

SKU: DAPXI_5MG_10_TABLET_PACK

Category: Tablets & Capsules

Dapagliflozin selectively inhibits sodium-glucose cotransporter 2 (SGLT2) in the proximal renal tubules, reducing renal glucose reabsorption and lowering the renal threshold for glucose. This biochemical blockade promotes insulin-independent glucosuria, directly removing excess glucose from the bloodstream while concurrently inducing mild osmotic diuresis and secondary caloric loss.

Purpose

It is indicated as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus, and to lower the risk of cardiovascular death and hospitalization in heart failure or chronic kidney disease.

Ingredients

Dapagliflozin

Warnings

- Do not initiate this drug if you are prone to diabetic ketoacidosis or possess severely impaired renal function with an eGFR below minimal cutoffs.\n- Seek immediate emergency medical care if you experience severe, persistent genital pain, swelling, and redness accompanied by a fever, which may indicate perineal necrotizing fasciitis.\n- Maintain optimal hydration and meticulous perineal hygiene during therapy to significantly reduce the risk of urogenital tract infections.

Side Effects

- You may experience an increased frequency of urination, greater volume of urine, or mild urgent voiding.\n- Genital mycotic infections, such as vulvovaginal candidiasis or balanitis, are common due to high urinary glucose levels.\n- Transient dizziness or a lightheaded feeling can occur, secondary to a mild drop in blood pressure from volume depletion.